Multiplex PCR, also known as multiplex primer PCR or multiplex PCR, is a PCR reaction in which more than two pairs of primers are added to the same PCR reaction system, and at the same time, multiple nucleic acid fragments are amplified The Reaction Reagent and the operation process are the same as the ordinary PCR. In general, PCR only uses a pair of primers and produces a nucleic acid fragment by PCR amplification, which is mainly used for the identification of single pathogenic factor.Multiplex PCR is mainly used to detect and identify some pathogenic microorganisms, some genetic diseases and genotyping of oncogenes.
The global Multiplex PCR Assays market is projected to reach US$ 1855.6 million in 2029, increasing from US$ 1103 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029.
Key companies engaged in the Multiplex PCR Assays industry include Abbott, Siemens, Roche, Agena Bioscience, BD, PerkinElmer, Luminex, QIAGEN and Agilent Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Multiplex PCR Assays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Multiplex PCR Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiplex PCR Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Siemens
Roche
Agena Bioscience
BD
PerkinElmer
Luminex
QIAGEN
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Seegene
Olink
Illumina
Bio-Rad Laboratories
Abcam
Quanterix
Segment by Type
Products
Services
Segment by Application
Hospitals
Pharmaceutical & Biotechnology Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Multiplex PCR Assays report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex PCR Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Products
1.2.3 Services
1.3 Market by Application
1.3.1 Global Multiplex PCR Assays Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplex PCR Assays Market Perspective (2018-2029)
2.2 Multiplex PCR Assays Growth Trends by Region
2.2.1 Global Multiplex PCR Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiplex PCR Assays Historic Market Size by Region (2018-2023)
2.2.3 Multiplex PCR Assays Forecasted Market Size by Region (2024-2029)
2.3 Multiplex PCR Assays Market Dynamics
2.3.1 Multiplex PCR Assays Industry Trends
2.3.2 Multiplex PCR Assays Market Drivers
2.3.3 Multiplex PCR Assays Market Challenges
2.3.4 Multiplex PCR Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex PCR Assays Players by Revenue
3.1.1 Global Top Multiplex PCR Assays Players by Revenue (2018-2023)
3.1.2 Global Multiplex PCR Assays Revenue Market Share by Players (2018-2023)
3.2 Global Multiplex PCR Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplex PCR Assays Revenue
3.4 Global Multiplex PCR Assays Market Concentration Ratio
3.4.1 Global Multiplex PCR Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex PCR Assays Revenue in 2022
3.5 Multiplex PCR Assays Key Players Head office and Area Served
3.6 Key Players Multiplex PCR Assays Product Solution and Service
3.7 Date of Enter into Multiplex PCR Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex PCR Assays Breakdown Data by Type
4.1 Global Multiplex PCR Assays Historic Market Size by Type (2018-2023)
4.2 Global Multiplex PCR Assays Forecasted Market Size by Type (2024-2029)
5 Multiplex PCR Assays Breakdown Data by Application
5.1 Global Multiplex PCR Assays Historic Market Size by Application (2018-2023)
5.2 Global Multiplex PCR Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Multiplex PCR Assays Market Size (2018-2029)
6.2 North America Multiplex PCR Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multiplex PCR Assays Market Size by Country (2018-2023)
6.4 North America Multiplex PCR Assays Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex PCR Assays Market Size (2018-2029)
7.2 Europe Multiplex PCR Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multiplex PCR Assays Market Size by Country (2018-2023)
7.4 Europe Multiplex PCR Assays Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplex PCR Assays Market Size (2018-2029)
8.2 Asia-Pacific Multiplex PCR Assays Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multiplex PCR Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Multiplex PCR Assays Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplex PCR Assays Market Size (2018-2029)
9.2 Latin America Multiplex PCR Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multiplex PCR Assays Market Size by Country (2018-2023)
9.4 Latin America Multiplex PCR Assays Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex PCR Assays Market Size (2018-2029)
10.2 Middle East & Africa Multiplex PCR Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multiplex PCR Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Multiplex PCR Assays Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Multiplex PCR Assays Introduction
11.1.4 Abbott Revenue in Multiplex PCR Assays Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens Multiplex PCR Assays Introduction
11.2.4 Siemens Revenue in Multiplex PCR Assays Business (2018-2023)
11.2.5 Siemens Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Multiplex PCR Assays Introduction
11.3.4 Roche Revenue in Multiplex PCR Assays Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Agena Bioscience
11.4.1 Agena Bioscience Company Detail
11.4.2 Agena Bioscience Business Overview
11.4.3 Agena Bioscience Multiplex PCR Assays Introduction
11.4.4 Agena Bioscience Revenue in Multiplex PCR Assays Business (2018-2023)
11.4.5 Agena Bioscience Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Multiplex PCR Assays Introduction
11.5.4 BD Revenue in Multiplex PCR Assays Business (2018-2023)
11.5.5 BD Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Multiplex PCR Assays Introduction
11.6.4 PerkinElmer Revenue in Multiplex PCR Assays Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 Luminex
11.7.1 Luminex Company Detail
11.7.2 Luminex Business Overview
11.7.3 Luminex Multiplex PCR Assays Introduction
11.7.4 Luminex Revenue in Multiplex PCR Assays Business (2018-2023)
11.7.5 Luminex Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Multiplex PCR Assays Introduction
11.8.4 QIAGEN Revenue in Multiplex PCR Assays Business (2018-2023)
11.8.5 QIAGEN Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Multiplex PCR Assays Introduction
11.9.4 Agilent Technologies Revenue in Multiplex PCR Assays Business (2018-2023)
11.9.5 Agilent Technologies Recent Development
11.10 Meso Scale Diagnostics
11.10.1 Meso Scale Diagnostics Company Detail
11.10.2 Meso Scale Diagnostics Business Overview
11.10.3 Meso Scale Diagnostics Multiplex PCR Assays Introduction
11.10.4 Meso Scale Diagnostics Revenue in Multiplex PCR Assays Business (2018-2023)
11.10.5 Meso Scale Diagnostics Recent Development
11.11 Randox Laboratories
11.11.1 Randox Laboratories Company Detail
11.11.2 Randox Laboratories Business Overview
11.11.3 Randox Laboratories Multiplex PCR Assays Introduction
11.11.4 Randox Laboratories Revenue in Multiplex PCR Assays Business (2018-2023)
11.11.5 Randox Laboratories Recent Development
11.12 Seegene
11.12.1 Seegene Company Detail
11.12.2 Seegene Business Overview
11.12.3 Seegene Multiplex PCR Assays Introduction
11.12.4 Seegene Revenue in Multiplex PCR Assays Business (2018-2023)
11.12.5 Seegene Recent Development
11.13 Olink
11.13.1 Olink Company Detail
11.13.2 Olink Business Overview
11.13.3 Olink Multiplex PCR Assays Introduction
11.13.4 Olink Revenue in Multiplex PCR Assays Business (2018-2023)
11.13.5 Olink Recent Development
11.14 Illumina
11.14.1 Illumina Company Detail
11.14.2 Illumina Business Overview
11.14.3 Illumina Multiplex PCR Assays Introduction
11.14.4 Illumina Revenue in Multiplex PCR Assays Business (2018-2023)
11.14.5 Illumina Recent Development
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Detail
11.15.2 Bio-Rad Laboratories Business Overview
11.15.3 Bio-Rad Laboratories Multiplex PCR Assays Introduction
11.15.4 Bio-Rad Laboratories Revenue in Multiplex PCR Assays Business (2018-2023)
11.15.5 Bio-Rad Laboratories Recent Development
11.16 Abcam
11.16.1 Abcam Company Detail
11.16.2 Abcam Business Overview
11.16.3 Abcam Multiplex PCR Assays Introduction
11.16.4 Abcam Revenue in Multiplex PCR Assays Business (2018-2023)
11.16.5 Abcam Recent Development
11.17 Quanterix
11.17.1 Quanterix Company Detail
11.17.2 Quanterix Business Overview
11.17.3 Quanterix Multiplex PCR Assays Introduction
11.17.4 Quanterix Revenue in Multiplex PCR Assays Business (2018-2023)
11.17.5 Quanterix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott
Siemens
Roche
Agena Bioscience
BD
PerkinElmer
Luminex
QIAGEN
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Seegene
Olink
Illumina
Bio-Rad Laboratories
Abcam
Quanterix
Ěý
Ěý
*If Applicable.
